Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: A case series

American Journal of Gastroenterology

Volumn 105, Issue 12, 2010, Pages 2707-2709

  Kenny, Patrick R ^a   Brady, Daniel E ^a   Torres, Dawn M ^a   Ragozzino, Linda ^b   Chalasani, Naga ^b   Harrison, Stephen A ^a  

^a San Antonio Uniformed Services Health Education Consortium   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; EXENDIN 4; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; DIABETIC PATIENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; LIVER BIOPSY; LIVER CELL; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SATIETY; STOMACH EMPTYING; TREATMENT WITHDRAWAL; WEIGHT REDUCTION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; MALE; MIDDLE AGED; PEPTIDES; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOMS;

EID: 78649878256     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.363     Document Type: Letter

References (11)

1. Afdhal N, McHutchison J, Brown R et al. Trombocytopenia associated with chronic liver disease. J Hepatol 2008;48: 1000-7.
2. Amitrano L, Guardascione MA, Brancaccio V et al. Coagulation disorders in liver disease. Semin Liver Dis 2002;22: 83-96.
3. Garcia-Tsao G. Gut microfl ora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004;18: 353-72.
4. Goulis J, Patch D, Burrough AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999;353: 139-42.
5. Moncada S, Higgs A. Th e L-arginine-nitric oxide pathway. N Engl J Med 1993;329: 2002-12.
6. Panasiuk A, Zak J, Kasprzycka E et al. Blood platelet and monocyte activations and relation to stages of liver cirrhosis. World J Gastroenterol 2005;11: 2754-8.
7. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastro enterology 1992;103: 264-74.
8. Lee JW, Beckham C, Michel BR et al. HLA-DRmediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway. Blood 1997;90: 217-25.
9. Schattner M, Pozner RG, Engelberger I et al. Effect of nitric oxide on megacaryocyte growth induced by thrombopoietin. J Lab Clin Med 2001;137: 261-9.
10. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010;26: 17-25.
11. Vlachogiannakos J, Saveriadis AS, Viazis N et al. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Th er 2009;29: 992-9.